Microbiome Therapeutics

MicroBiome Therapeutics, LLC, a biotechnology company, develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics, LLC was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.
Type
Private
HQ
New Orleans, US
Founded
2009
Employees
5 (est)
Microbiome Therapeutics was founded in 2009 and is headquartered in New Orleans, US

Key People at Microbiome Therapeutics

Steve Orndorff

Steve Orndorff

President & CEO
Mark Heiman

Mark Heiman

CSO

Microbiome Therapeutics Locations

New Orleans, US

Microbiome Therapeutics Metrics

Microbiome Therapeutics Summary

Founding Date

2009

Total Funding

$1.3 M

Latest funding size

$743 K

Time since last funding

over 1 year

Investors

We estimate that Microbiome Therapeutics's latest funding round in June 2015 was $743 K. In total, Microbiome Therapeutics has raised $1.3 M

Microbiome Therapeutics News

Microbiome Therapeutics Company Life

You may also be interested in